Fellow Investor,

Space medicine is a new scientific breakthrough that could make it possible to live 20, perhaps even 30 years longer than today.

It could even usher in the “death of death.”

Space medicine uses the low-gravity environment of space to produce advanced new medicines, where it’s possible to assemble the delicate chemical compounds of incredible new drugs that can’t be made on Earth.

Space medicine can finally solve...

• Aggressive cancers — making them disappear completely in a matter of months, saving tens of thousands of lives every year
• Autoimmune disorders — giving patients a new lease on longevity
• And antibiotic-resistant viruses — the so-called “superbugs” that continue to kill more and more Americans. This breakthrough could hit “superbugs” so hard that millions of people would instantly see improved quality of life

Scientists don’t need to make any new drug discoveries for this breakthrough to work — because these medical compounds already exist!

Scientists have known about these medicines, cures, and life-extensions for decades.

But gravity has kept all of these next-generation medicines from getting off the ground.

That is, until now...

Even though it’s impossible to make these compounds on Earth, they’re easy to formulate in the low-gravity environment of space.

Companies like Merck are already making billions.

And ultra-wealthy investors like Jeff Bezos, Elon Musk, and Bill Gates are already buying up their stake.

New drugs are already in production.

As Wired Magazine put it in a recent article: “The Next Generation of Cancer Drugs Will Be Made in Space.”

And one small space firm is making it all possible.

They’ve already helped produce several new medicines and returned them back to Earth, where they’ve made a life-saving difference for patients.

Here’s how it works...

This small space firm has designed custom-built, reusable capsules that can easily be put into space and then brought back down.

They’re compact, inexpensive, and automatically produce the medicine using robotic machinery inside.

They can also be put into space in just a fraction of the time of current space missions.

In short, this small space firm is going to change the future of medicine.

But that’s not all.

This small space firm is also quickly becoming one of the most innovative companies in the commercial space industry — which McKinsey says will grow to a $1.8 trillion industry by 2035.

And the timing couldn’t be better...

America Can Only Be Great with Space

As you heard today, the space race is back on.

This small space firm is going to benefit from the billions in new funding that’s pouring into America’s reach into the final frontier.

For example, they were handpicked by NASA to build two Mars orbital satellites that’ll be a key part of Trump’s announced Mars missions.

They also have a $5.6 billion contract to supply the Space Force with its new lineup of rockets.

And then here’s what matters most for us as investors...

This space firm’s stock price is extremely undervalued given all of the innovations they’re producing.

At the current share price, the market cap of this space firm is just $15 billion.

While impressive for a small firm, it’s an absolute steal when compared to SpaceX, the one and only benchmark that industry insiders are using.

Better Than SpaceX, At A Fraction of the Price

SpaceX is currently valued at over $350 billion.

In fact, SpaceX is now the largest and most expensive private company in the world.

Their valuation proves just how lucrative the space industry has become — and everybody wants a piece of it.

Wall Street is desperate to buy shares of SpaceX, but they can’t... because it’s a private company and it’s tightly controlled by its CEO and founder Elon Musk.

“How to buy shares of SpaceX” is even one of the most-searched terms on the internet.

But in our opinion those investors are wasting their time and money if they’re holding out for SpaceX.

Because there’s a much better deal out there for investors...

And that’s the small space firm we’re talking about today.

This space firm has benefitted from the success of SpaceX, and as their number of rocket launches continues to increase, they’ve been catching up quickly.

As this space firm’s CEO recently said in an interview:

“So as we continue to execute, the gap between our two businesses continues to shrink more and more and more. We’re currently valued at less than 5% of SpaceX, but give it a few more years.”

This small space firm is an outstanding deal, especially when you consider...

• They have a better success record than SpaceX
• They have a better safety record than SpaceX
• They have a wider variety of rockets and mission capabilities

To sum it all up, you can get SpaceX-level exposure at a tiny fraction of the price.

And then, most important of all, this small space firm is the only company in the world that can bring us space medicine.

We can’t predict the future.

But we can predict the fact that Big Pharma is putting billions of dollars into unlocking the power of space medicine — and only one company in the world can build these custom satellites.

Future cures to cancer, Alzheimer’s, and autoimmune disorders are waiting to be made.

The compounds have already been discovered, now they just need the low-gravity environment of space to be produced.

We’ve put everything you need to know in a new special report, which we’d like to rush to you today.

You’ll discover...

• The name, ticker symbol, and precise buy recommendation for this small space firm
• 100% original research on this unique company that you can’t find anywhere else, including our breakdown of their launch schedule, contract pipeline, and financials. It also includes access to quotes from the company’s CEO and management team
• An overview of the space medicine program and Big Pharma’s plans for new, low-gravity-produced drugs

This report contains everything you need to make the most of this opportunity — just as we’ve done before for other fast-moving tech discoveries.

Our readers have proven that they’ve been able to make triple-digit gains on previous reports we’ve published.

One of these readers, named Zach T, wrote this to us just last year:

“Just reaching out to say thank you... I was thrilled to walk away with a 300% gain in just 4 months. Thanks for the recommendation!”
— Zach T, Eau Claire, WI

It’s our goal to show you returns like these.

The research in this special report is truly impossible to find anywhere else, and it’s included as part of your paid subscription to our premium tech publication Digital Dispatch.

But that’s not all you’ll receive...

You’ll Receive 2 Bonus Reports
When You Become a VIP Member

If you choose a VIP 2-year subscription, you’ll also receive two exclusive BONUS REPORTS to further sweeten the deal.

The timing of these reports is crucial...

Because, as you’ve likely seen in the news, America is about to go head-to-head with China in an all-out AI Arms Race.

Trillions of dollars are on the line, and America’s biggest tech companies are playing for keeps.

Investors stand to make a fortune on Big Tech’s record-breaking shopping spree for more AI technologies.

The unique research in these reports will show you how to make the biggest gains on this epic showdown for AI superiority.

America’s AI Arms Race with China is Driving Incredible Profits for Tech Investors

• Bonus Report #1: “The Silicon Trail to AI Profits”
  
  In this AI gold rush, chips and wafers are the new picks and shovels. It’s impossible to mine new AI discoveries without them — and chip makers are well-positioned to get paid first. The company in this report is essential to the chip industry. This report is a must-read for how to position for the trillions of dollars flowing into AI.
• Bonus Report #2: “AI Buyout Frenzy: The 3 Small AI Stocks That Could Make You 1,000% or More In the Weeks Ahead.”
  
  All of Silicon Valley is racing to catch up to this massive leap in AI capability. Small, innovative AI firms are about to receive record-setting buyout offers. We’ve put together a report that covers the 3 AI firms that’ll be at the top of everyone’s list — and why they’re delivering outstanding returns for smart tech investors.

You’ll receive these bonus reports when you choose the 2-year VIP subscription option using the form below.

Getting Started is Simple

The moment you become a subscriber, you'll have access to all of the premium features of Digital Dispatch:

• 24/7 Access to the Digital Dispatch Website
  
  This includes our Tech Trends dashboard, which shows you exactly what tech innovations to follow (and which ones to avoid)
• Monthly Issues
  
  You’ll receive a new issue at the beginning every single month — 12 action-packed issues a year. Each issue contains articles, portfolio updates, and an overview of what’s happening in the markets
• Our Digital Dispatch Model Portfolio
  
  We put a lot of time and research into choosing the best tech stocks. Includes actionable buy and sell recommendations. Also includes our top ETF picks
• Breaking-News Alerts
  
  Innovation is never still — and neither are we. If anything changes with one of our positions, we’ll send you an urgent update so you don’t miss out
• A Reserved Spot to Our 4 Quarterly Tech Summits Per Year
  
  These are special events where you'll get to hear our take on a relevant topic in tech. Best of all, these are interactive events where you can ask us all of your questions (and hear questions from other investors)
• Videos and Special Reports
  
  This series of videos and reports will teach you our secret system for mastering the markets. You’ll learn step-by-step how we find stocks that outperform the rest. We’ve just launched the first few episodes, and new topics will be coming out each month

Why Do We Love Tech? — Because it
Consistently Outperforms

For over 40 years technology has been one of the highest-performing market sectors.

And yet we’ve never seen more world-changing, profit-generating power than right now.

Our Digital Dispatch portfolio has continually reaped giant rewards for our readers.

At the beginning of 2023, with AI’s growing importance on the horizon, we wrote a special report recommending that our readers buy Nvidia — this was BEFORE it became major news... and we were well ahead of the crowd.

The rest of Wall Street came piling in once the word was out, giving us a gain of 663%.

That’s an actual closed return in the Digital Dispatch portfolio.

And then we also made 335% on the AI / cybersecurity firm Palantir, once again getting into the stock before Wall Street.

Here’s why our research is so unique...

• We cut through the hype and discover what’ll make a difference for your portfolio. For example, our Tech Trends dashboard on the Digital Dispatch homepage will show you what to follow, steering you clear of surprise moves caused by inflation, the Fed, Big Banks, Wall Street insiders, and the other major factors that affect your portfolio.
• We’ll give you access to the Digital Dispatch model portfolio, which has all of our recommendations in one place. You’ll be able to see at a glance what we’re buying and selling — and at what price.
• And most importantly, we’ll guide you with monthly issues and timely alerts that are engaging, easy-to-read, and brimming with ways to make money on all the growth in the tech industry.

And then, best of all, Digital Dispatch will show you an incredible amount of value at a price that’s reasonable.

You’ll get all of this and more for much less than you might think — we’re offering it to you today at the lowest subscription price possible, which we’ve listed on the order form below.

And there’s no risk to you if you don’t love everything you see...

You're Always in Control

Our publisher completely guarantees your satisfaction — 100%.

You'll have a full 60 days to try the service out completely risk-free for yourself.

If for any reason our research isn’t right for you — no problem at all, you can get every penny back with no hassles or runarounds.

But we think you’ll love what you see.

That’s it!

We look forward to showing you what the research in Digital Dispatch can do for you.

The future won’t wait,

John Carl and Chris Curl
Editors, Digital Dispatch

Simply Choose Your Subscription Level

If you prefer to order by phone, please call our Member Services team toll-free at 844-334-4700 and mention "Digital Dispatch" to receive everything outlined above at today's low price.